Aditxt, Inc. (NASDAQ:ADTX – Get Free Report) major shareholder Financial Lp Hrt sold 3,132,480 shares of Aditxt stock in a transaction dated Tuesday, June 16th. The stock was sold at an average price of $0.01, for a total value of $31,324.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Financial Lp Hrt also recently made the following trade(s):
- On Friday, June 12th, Financial Lp Hrt bought 4,252,767 shares of Aditxt stock. The shares were acquired at an average price of $0.02 per share, for a total transaction of $85,055.34.
- On Friday, June 5th, Financial Lp Hrt sold 735,462 shares of Aditxt stock. The shares were sold at an average price of $0.06, for a total transaction of $44,127.72.
- On Thursday, June 4th, Financial Lp Hrt purchased 843,622 shares of Aditxt stock. The shares were acquired at an average price of $0.08 per share, with a total value of $67,489.76.
- On Friday, April 24th, Financial Lp Hrt sold 1,089 shares of Aditxt stock. The stock was sold at an average price of $7.56, for a total transaction of $8,232.84.
- On Thursday, April 23rd, Financial Lp Hrt sold 141 shares of Aditxt stock. The shares were sold at an average price of $7.83, for a total transaction of $1,104.03.
- On Tuesday, April 21st, Financial Lp Hrt acquired 2,700 shares of Aditxt stock. The stock was acquired at an average cost of $8.91 per share, for a total transaction of $24,057.00.
- On Wednesday, April 22nd, Financial Lp Hrt sold 443 shares of Aditxt stock. The stock was sold at an average price of $8.10, for a total transaction of $3,588.30.
Aditxt Stock Performance
Shares of Aditxt stock opened at $0.01 on Friday. The firm has a fifty day moving average of $3.71 and a two-hundred day moving average of $125.11. The stock has a market capitalization of $8,528.00, a price-to-earnings ratio of -0.00 and a beta of 0.84. Aditxt, Inc. has a 52 week low of $0.00 and a 52 week high of $53,451.08.
Analyst Upgrades and Downgrades
ADTX has been the subject of several analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of Aditxt in a research report on Monday, April 20th. Wall Street Zen upgraded shares of Aditxt to a “sell” rating in a research report on Saturday, May 23rd. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.
Read Our Latest Analysis on ADTX
About Aditxt
Aditxt, Inc is a clinical-stage biotechnology company focused on the development and commercialization of natural antimicrobial peptides and microbiome-based detection technologies. Leveraging proprietary peptide libraries, the company aims to provide novel solutions for infection prevention and control across healthcare, food safety, animal health and agricultural markets. Aditxt’s approach centers on harnessing peptides that can disrupt microbial cell membranes without promoting resistance, addressing a growing need for alternatives to traditional antibiotics and chemical disinfectants.
The company’s product offerings include contract-based microbial detection and identification services, designed to help hospitals, food processors and other regulated industries monitor contamination levels and validate hygiene protocols.
See Also
- Five stocks we like better than Aditxt
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Receive News & Ratings for Aditxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aditxt and related companies with MarketBeat.com's FREE daily email newsletter.
